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Irritable bowel syndrome (IBS) aﬀects up to 22% of the general population. Its aetiology remains unclear. Previously reported
cross-sectional associations with psychological distress and depression are not fully understood. We hypothesised that psychosocial
factors, particularly those associated with somatisation, would act as risk markers for the onset of IBS. We conducted a community-
based prospective study of subjects, aged 25–65 years, randomly selected from the registers of three primary care practices.
Responses to a detailed questionnaire allowed subjects’ IBS status to be classiﬁed using a modiﬁed version of the Rome II criteria.
The questionnaire also included validated psychosocial instruments. Subjects free of IBS at baseline and eligible for follow-up
15 months later formed the cohort for this analysis (n = 3732). An adjusted participation rate of 71% (n = 2456) was achieved at
follow-up. 3.5% (n = 86) of subjects developed IBS. After adjustment for age, gender and baseline abdominal pain status, high levels
of illness behaviour (odds ratio (OR) = 5.2; 95% conﬁdence interval (95% CI) 2.5–11.0), anxiety (OR = 2.0; 95% CI 0.98–4.1), sleep
problems (OR = 1.6; 95% CI 0.8–3.2), and somatic symptoms (OR = 1.6; 95% CI 0.8–2.9) were found to be independent predictors
of IBS onset. This study has demonstrated that psychosocial factors indicative of the process of somatisation are independent risk
markers for the development of IBS in a group of subjects previously free of IBS. Similar relationships are observed in other ‘‘func-
tional’’ disorders, further supporting the hypothesis that they have similar aetiologies.
 2007 International Association for the Study of Pain. Published by Elsevier B.V.
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The term functional gastrointestinal (GI) disorders
(FGIDs) describes a group of syndromes related to the
GI tract but for which no structural cause has been iden-0304-3959  2007 International Association for the Study of Pain. Publishe
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E-mail address: John.McBeth@manchester.ac.uk (J. McBeth).tiﬁed [34]. FGIDs are common both in community and
clinic populations [5,18,24]. One of the common FGID
symptoms is pain [11,34]. Two recent studies reported
similar 12-month prevalence rates of self-reported
abdominal pain of 4–5% [11,17].
Irritable bowel syndrome (IBS), which has abdom-
inal pain as its cardinal symptom, is one of the most
common FGIDs. It has an estimated prevalence of 8–
22% in the general population [14,27,33]. A number ofd by Elsevier B.V. Open access under CC BY-NC-ND license.
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posed, including bacterial gastroenteritis [25] and
alterations of gut microﬂora [21,29]. However, psycho-
social factors are also thought to play an important
role and may act as markers of IBS onset, in particu-
lar those associated with the process of somatisation,
deﬁned as the manifestation of psychological symp-
toms as bodily disorders [16]. A number of studies
have investigated the relationship between psychoso-
cial factors and IBS; two of the most recent showing
that subjects with IBS have higher levels of depres-
sion, anxiety and neuroticism, compared with subjects
free of IBS [18,20]. An association between psycholog-
ical distress and consulting a physician with IBS
symptoms has also been demonstrated [6,30,36]. How-
ever it is not known whether psychological distress
and other psychosocial factors act as risk markers
for IBS onset or are merely associated with the pres-
ence of IBS symptoms. In order to elucidate this tem-
poral relationship prospective studies are essential.
The aim of the current study was to test the
hypothesis that among a group of subjects free of
IBS, psychosocial markers, particularly those associ-
ated with the process of somatisation, would predict
the onset of IBS at follow-up.
2. Methods
2.1. Study design
We conducted a prospective population-based postal
survey that ascertained at baseline participants’ psychosocial
status and identiﬁed abdominal symptoms using a modiﬁed
version of the Rome II criteria for IBS [4]. After 15 months
all eligible subjects (those who provided full information and
agreed to further contact at baseline) who were free of IBS
at baseline were followed up with a further postal survey.
Methods for recording and classifying IBS were identical to
the baseline survey, as was the mailing strategy. Participants
reporting IBS at follow-up were identiﬁed.
2.2. Study subjects
Individuals aged between 25 and 65 years were randomly
selected from the population-based registers of three general
practices in socio-economically diverse areas of North West
England.
2.3. Baseline questionnaire
All subjects were mailed a full baseline questionnaire.
The Rome II criteria for classifying IBS [4], of which we
used a modiﬁed version, are widely used in both clinic
and general population settings to classify IBS [28]. We
asked participants to recall any abdominal pain, in the past
month rather than over the past year as in the original
Rome II criteria, in order to reduce the inaccurate recall
that has previously been demonstrated over a 12-month per-iod [19]. Participants were classiﬁed as having IBS if they
reported having experienced abdominal pain (as described
above) and in addition answered yes to at least two of the
following questions: (1) ‘‘Was your abdominal pain or dis-
comfort relieved by opening your bowels?’’ (2) ‘‘During
the past month have you had fewer than three bowel move-
ments a week OR more than three bowel movements a
day?’’ (3) ‘‘During the past month have you had hard or
lumpy stools OR loose or watery stools?’’ Subjects free of
IBS were sub-classiﬁed into one of two groups depending
on their abdominal pain status: abdominal pain free or
abdominal pain.
An intensive mailing strategy was used to boost response
rates. At each stage subjects were free to refuse participa-
tion. The remaining non-responders were contacted at 2-
week intervals over an 8-week period, correspondence
involved a reminder postcard to complete the ﬁrst question-
naire, followed by a mailed second full questionnaire to the
non-responders. For those still not responding a short (two
page) questionnaire followed, if necessary, by a short tele-
phone questionnaire, and used to characterise any potential
non-response bias. The current analysis uses data from the
full detailed questionnaire only.
The full baseline questionnaire also included measures of
psychosocial status. These measures were:
2.3.1. Estimation of Sleep Problems Scale [13]
This is a validated 4-item scale used to assess recent prob-
lems with sleep. Each item is scored in a range of 0–5, giving
a total score of between 0 and 20.
2.3.2. General Health Questionnaire (GHQ) [7]
This 12-item version of the GHQ measures levels of psycho-
logical distress and has been widely used for previous popula-
tion-based studies [22]. Each item has four possible responses,
for scoring purposes these are dichotomised (0 or 1) and the 12
scores added together to give a total GHQ score between 0 and
12. Higher total scores indicate higher levels of psychological
distress.
2.3.3. Somatic Symptoms Checklist [26]
This checklist was originally developed and validated as a
screening test for somatisation disorder. It contains six basic
items regarding lifetime history of symptoms; troubled breath-
ing, frequent pain in ﬁngers or toes, frequent vomiting (when
not pregnant), loss of voice, loss of memory and diﬃculty
swallowing. A further 7th item, frequent trouble with men-
strual cramps, is included for female participants. However,
to avoid spurious associations with the onset of IBS this ques-
tion was not included in the total score. A second question,
‘‘Have you ever had diﬃculties swallowing or had an uncom-
fortable lump in your throat that stayed with you for at least
an hour?’’, was also excluded from the analysis due to a high
proportion of missing answers. The total score therefore ran-
ged between 0 and 5 for both males and females.
2.3.4. The Illness Attitudes Scales (IAS) [15]
The IAS measure two particular dimensions, ‘‘Health
Anxiety’’ and ‘‘Illness Behaviour’’ [31]. The ‘‘Health Anxiety’’
subscale consists of 11 items (such as ‘‘Are you worried that
B.I. Nicholl et al. / Pain 137 (2008) 147–155 149you may get a serious illness in the future?’’) and has a total
score between 0 and 44, with a general population mean score
of 9.1 (standard deviation 6.9). The ‘‘Illness Behaviour’’ sub-
scale consists of six items (such as ‘‘How often do you see a
doctor?’’) and has a total score between 0 and 24, with a gen-
eral population mean score of 4.7 (standard deviation 4.2).
2.3.5. Hospital Anxiety and Depression Scale (HAD) [37]
The HAD scale measures levels of anxiety and depression
and concentrates on symptoms experienced in the past week.
The 14 items are coded on a 0–3 Likert scale, and anxiety
and depression scores are totalled separately. Scores on each
subscale of 10–11 represent a high probability of an anxiety
or depression disorder being present.2.3.6. Threatening life events [3]
The 12 items in this inventory gather information on
adverse life events experienced within the previous 6 months.
The events are associated with a signiﬁcant long-term contex-
tual threat rating and include questions on personal relation-
ships, employment, illness, and ﬁnancial and legal problems.
It is a modiﬁed version of Tennant and Andrew’s 67-item life
events inventory [35]. The total score of between 0 and 12 is
representative of the number of events experienced.
2.4. Statistical analysis
Those subjects who provided complete data at baseline
and follow-up were included in the analysis. For each of
the psychological measures, based upon the distribution, par-
ticipants’ scores were categorised into thirds. This method
accounts for the non-Gaussian distribution of these scores.
The association between being in the middle or highest third
compared to the lowest third (referent group) of the psycho-
social scale scores and the onset of IBS was examined using
logistic regression. Results are presented as odds ratios
(OR) with 95% conﬁdence intervals (CI). All factors found
to be associated (statistically signiﬁcant association, or
OR < 0.67 or ORP 1.5 [12]) with the onset of IBS in the
univariate model were entered into a multivariate model. This
enabled us to examine the relative contribution of these fac-
tors to the development of IBS. Univariate and multivariate
logistic regression models were adjusted for age and gender.
The multivariate model was also adjusted for baseline
abdominal pain status.
To examine the performance of the ﬁnal model we exam-
ined the (1) multiplicative and (2) additive eﬀects of the risk
markers we had identiﬁed as important predictors of outcome.
All factors that remained strong independent predictors in the
multivariate model were dichotomised (0 or 1) at the point
where an increased risk of the onset of IBS was observed.
We then explored whether there were any interactive eﬀects,
over and above the individual contributions, of those factors
and the onset of IBS. To explore the additive eﬀects of the
important variables we explored whether the risk of new IBS
increased as the number of factors subjects were exposed to
at baseline increased. The analyses of model performance were
adjusted for age, gender and baseline abdominal pain status.
All statistical analyses were carried out using the STATA sta-
tistical software package [32].This study received ethical approval from both the South
Manchester and East Cheshire Local Research Ethics
Committees.
3. Results
3.1. Baseline data
A total of 6094 subjects provided complete informa-
tion on IBS status, of who 14% (n = 844) had IBS and
86% (n = 5250) were free of IBS.
3.2. Follow-up response rates and study subjects
Of the 5250 subjects free of IBS at baseline 3732 were
eligible for follow-up 15 months later (see Fig. 1). After
adjusting for those who had moved or died (n = 279),
83% of subjects participated at follow-up and 2456
(71%) provided complete follow-up information that
allowed us to classify their IBS status.
3.3. Prevalence of IBS at follow-up
As shown in Table 1, of the 2456 who were free of
IBS at baseline and on whom we had complete follow-
up information, 86 subjects reported IBS (prevalence
3.5%) at follow-up. The onset rate of IBS was signiﬁ-
cantly higher in both women (4.6% compared to 2.1%
in men; v2 test for diﬀerence p < 0.01) and younger sub-
jects (median age of 44.1 years compared to 47.7 years;
p = 0.01). Of all subjects who were free of IBS at base-
line 327 (13.3%) reported having abdominal pain. The
rate of new IBS at follow up was higher among subjects
with some abdominal pain (n = 25, 7.6%) when com-
pared to those with no abdominal pain (n = 61, 2.9%).
3.4. Psychosocial factors as predictors of the onset of IBS
Scores on each of the baseline psychosocial measures
were higher, reﬂecting a poorer psychosocial state, in
those who reported IBS at follow-up compared to those
who remained symptom free (Table 1). When we quan-
tiﬁed those relationships using logistic regression (Table
2) we found that, in univariate analysis adjusted for age
and gender, participants scoring in the highest third of
the Illness Behaviour Scale were seven times more likely
to develop IBS, whilst scoring in the top-third of the
Estimation of Sleep Problems and HAD Anxiety scales
were associated with a threefold increase and the
Somatic Symptom Checklist with over a 2-fold increase,
in the risk of developing IBS. Being in the highest third
of the GHQ, Health Anxiety, HAD Depression and
Threatening Life Event scales were also associated with
reporting IBS at follow-up. In addition, those subjects
who reported abdominal pain at baseline were 2.6 times
(OR = 2.59; 95% CI 1.6–4.2) more likely to develop IBS
Eligible for follow-up participation
n = 3453
Non / incomplete-participants††
n = 997 (28.9%)
Full participants at follow-up†
n = 2456 (71.1%)
IBS free at follow-up
n = 2370 (96.5%)
IBS at follow-up
n = 86 (3.5%) 
Follow-up questionnaire sent 
n = 3732
Deceased
n = 4
Moved
n = 275
Full participants at baseline†
n = 6094
IBS free at baseline
n = 5250 (86%)
IBS at baseline
n = 844 (14%)
Incomplete psychosocial 
information*
n = 539
Agreed to further contact
n = 4271(81.2%)
Did not agree to further contact
n = 979 (18.8%)
Fig. 1. Flowchart of study participation. *Incomplete psychosocial information at baseline = not eligible for participation in follow-up. Full
participants are those who completed a long questionnaire and provided complete data at follow-up.  Breakdown of non/incomplete
participants at follow-up: unable to classify due to incomplete data or completion of a short or telephone questionnaire n = 403, non-
participants n = 594.
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line may act to confound the relationship between psy-
chosocial factors and IBS at follow up we adjusted for
this factor in subsequent analyses.
In multivariate analysis (Table 2) subjects reporting
higher levels of somatic symptoms, sleep problems and
anxiety (as measured by the HAD scale) at baseline
had an increased odds of reporting IBS at follow-up.
However, the conﬁdence intervals around these esti-
mates included unity, although they approached signiﬁ-
cance. A high score on the Illness Behaviour Scale
remained the best predictor of outcome.3.5. Model assessment
We then examined the risk of developing IBS by a
combination of one or more of the associated psycho-
social risk markers (scoring in the highest third of the
HAD Anxiety Scale and Estimated Sleep Problems
Scale and in the highest two-thirds of the Somatic
Symptoms Checklist and Illness Behaviour Scale).
First we explored whether these variables interacted
with each other in predicting outcome. No interactive
eﬀects were observed (e.g. illness behaviour and sleep:
OR = 0.69; 95% CI 0.2–2.5). We then examined the
Table 1
Baseline measures and IBS status of full participants at follow-up
IBS free at FU (n = 2370) IBS at FU (n = 86) p-valuea
n % n %
Gender
Male 1069 97.9 23 2.1 <0.01
Female 1301 95.4 63 4.6
Total 2370 86
Median 95% CI Median 95% CI
Age 47.7 47.0–48.4 44.1 39.4–47.2 0.01
n % n %
Baseline APb status
AP free 2068 97.1 61 2.9 <0.01
AP 302 92.4 25 7.6
Total 2370 86
Median 95% CI Median 95% CI
Psychosocial scales
Sleep problems 5 4–5 8 6–9 <0.01
GHQ 0 0–0 1.5 0–2.6 <0.01
Somatic Symptoms 0 0–0 1 1–1 <0.01
Health Anxiety 9 8–9 11 8–14 0.01
Illness Behaviour 4 4–4 8 6–8 <0.01
HAD Anxiety 5 5–5 8 6–9 <0.01
HAD Depression 2 2–3 4 3–5 <0.01
Life Eventsc 0 0–1 1 0–1 0.01
a All values are by Mann–Whitney U test except gender and baseline abdominal pain status, which were by v2 test.
b AP, abdominal pain.
c Life events score for 6 months prior to completion of the follow-up questionnaire.
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those subjects exposed to none of the risk markers
(n = 534) only one subject (1.2%) reported IBS at fol-
low-up. We therefore classiﬁed subjects exposed to
none or one of these factors as the referent group.
We observed a linear increase in the odds of develop-
ing IBS with increasing number of factors subjects
were exposed to at baseline (see Table 3). Indeed,
exposure to two or more of those factors identiﬁed
80.2% (n = 69) of all subjects reporting IBS at fol-
low-up.
3.6. Methodological issues
We were concerned with the possible eﬀects of non-
participation bias on our results. Table 4 compares the
baseline characteristics of all full participants
(n = 2456) with all non-participants (n = 1976). The
non-participants were those subjects who had returned
a baseline questionnaire but who refused further contact
(n = 979) and those who were non/incomplete partici-
pants at follow-up (n = 997) (see Fig. 1). Non-partici-
pants were more likely to be younger males. In
addition they had signiﬁcantly diﬀerent HAD depres-
sion (p = 0.01) and illness behaviour scores (p = 0.03)
although no diﬀerences were observed in baseline
abdominal pain status between the two groups.4. Discussion
We have conducted a prospective study among sub-
jects free of IBS, the ﬁrst to have speciﬁcally considered
psychosocial risk markers for the onset of IBS in a com-
munity sample. Individuals in the oldest age group were
signiﬁcantly less likely to develop IBS at follow-up.
After adjustment for age we have shown that high levels
of illness behaviour, somatic symptoms, sleep problems,
anxiety, depression, psychological distress, and health
anxiety predicted the onset of IBS. Those who reported
all four of these markers at baseline were six times more
likely to report IBS when compared to those who were
exposed to none or one marker. Due to the episodic nat-
ure of IBS it is unclear whether we have identiﬁed the
’’ﬁrst ever (incident)’’ or ‘‘new (recurring)’’ episodes of
the disorder, and we are unable to determine this in
the current study. Nevertheless we have demonstrated
that among subjects free of IBS at the time of assess-
ment, psychosocial factors are strong predictors of
developing IBS 15-months later.
When interpreting our results it is important to con-
sider a number of methodological issues. First, measure-
ment of psychosocial markers was by standardised, well-
validated scales. Any misclassiﬁcation with respect to
these is likely to be random and independent of the out-
come. Since such misclassiﬁcation would make a rela-
Table 2
Univariate and multivariate analysis of baseline psychosocial measures and new onset IBS at follow-up
Factor Category IBS free
(n = 2370)
IBS (n = 86) Univariatec Multivariated
n % n % OR 95% CI OR 95% CI
Potential confounding factors
Gender Male 1069 45.1 23 26.7 1.0 – 1.0 –
Female 1301 54.9 63 73.3 1.97 1.3–3.1 1.55 0.9–2.6
Age (years) 25–39 659 27.8 35 40.7 1.0 – 1.0 –
40–52 824 34.8 31 36.1 0.80 0.5–1.3 0.72 0.4–1.2
53–65 887 37.4 20 23.3 0.54 0.3–0.9 0.40 0.2–0.7
Baseline APa status AP free 2068 87.3 61 70.9 1.0 – 1.0 –
AP 302 12.7 25 29.1 2.59 1.6–4.2 1.89 1.2–3.2
Psychosocial Scales
GHQ 0 1348 56.9 37 43.0 1.0 – 1.0 –
1–2 453 19.1 15 17.5 1.14 0.6–2.1 0.80 0.4–1.6
3–12 569 24.0 34 39.5 2.03 1.3–3.3 0.83 0.4–1.6
Sleep Problems 0–3 950 40.1 17 19.8 1.0 – 1.0 –
4–8 779 32.9 31 36.0 2.01 1.1–3.7 1.44 0.7–2.8
9–20 641 27.0 38 44.2 3.09 1.7–5.5 1.59 0.8–3.2
Somatic Symptoms 0 1328 56.0 29 33.7 1.0 – 1.0 –
1 697 29.4 35 40.7 2.03 1.2–3.4 1.53 0.9–2.6
2–5 345 14.6 22 25.6 2.60 1.5–4.7 1.56 0.8–2.9
Health Anxiety 0–6 890 37.6 29 33.7 1.0 – 1.0 –
7–13 832 35.1 21 24.4 0.76 0.4–1.4 0.55 0.3–1.02
14–44 648 27.3 36 41.9 1.70 1.0–2.8 0.80 0.4–1.5
Illness Behaviour 0–3 996 42.0 12 14.0 1.0 – 1.0 –
4–7 856 36.1 29 33.7 2.73 1.4–5.4 2.56 1.2–5.3
8–24 518 21.9 45 52.3 7.41 3.9–14.2 5.22 2.5–11.0
HAD Anxiety 0–4 1006 45.0 23 26.7 1.0 – 1.0 –
5–7 667 28.1 17 19.8 1.11 0.6–2.1 0.96 0.5–1.9
8–21 637 26.9 46 53.5 3.01 1.8–5.0 2.00 0.98–4.1
HAD Depression 0–2 1203 50.8 32 37.2 1.0 – 1.0 –
3–5 659 27.8 22 25.6 1.31 0.8–2.3 0.83 0.4–1.6
6–21 508 21.4 32 37.2 2.35 1.4–3.9 0.73 0.4–1.5
Life Eventsb 0 1165 50.6 33 40.2 1.0 – 1.0 –
1 624 27.1 18 22.0 0.99 0.6–1.8 0.82 0.4–1.5
2–9 514 22.3 31 37.8 1.96 1.2–3.2 1.21 0.7–2.1
Note: missing data (n = 71) are not included in this analysis.
a AP, abdominal pain.
b Life events during the 6 months prior to completion of the follow-up questionnaire.
c All univariate models are adjusted for age and gender.
d The multivariate model includes all variables.
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ships are probably underestimates rather than
overestimates.
Second, the overall population prevalence of FGIDs,
including IBS, is relatively stable over 12–20 months but
the actual individuals suﬀering at any particular time
point may vary due to the combination of both the onset
and resolution of symptoms [33]. Due to this ﬂuctuating
nature of the disorder it is probable that some partici-
pants’ symptoms will have resolved in the intervening
15 months between baseline and follow-up.Wewill there-
fore not have ascertained the complete IBS case-load atfollow-up. However this is unlikely to have any impact
on the internal comparisons between psychosocial expo-
sures and symptom onset 15 months later.
Third, non-participation bias must be considered. We
had complete information on 71% of those baseline par-
ticipants eligible for follow-up. However we were con-
cerned about the eﬀects of subjects who either refused
further contact at baseline or those who were non/
incomplete responders at follow-up. Since the only con-
ceptual diﬀerence between these two groups is the time
of refusal we grouped them together as ‘‘non-partici-
pants’’. Non-participants were more likely to be younger
Table 3
Additive eﬀects of psychosocial risk markers in the onset of IBS
Number of factorsb Group size New IBS ORa 95% CI
n %
0 534 1 1.2
1.0
–
1 70 16 18.6
2 637 25 29.0 2.59 1.4–4.9
3 402 27 31.4 4.43 2.4–8.3
4 182 17 19.8 6.33 3.1–13.0
a All values are adjusted for age, gender and baseline abdominal pain
status.
b Scoring in the highest third of the HAD Anxiety Scale and
Estimated Sleep Problems Scale and in the highest two-thirds of the
Somatic Symptoms Checklist and Illness Behaviour Scale.
B.I. Nicholl et al. / Pain 137 (2008) 147–155 153males, to have higher scores on the HAD Depression
scale, and lower scores in the illness behaviour scale.
The illness behaviour scale was the strongest predictor
of outcome. For this to impact on the current ﬁndings
we would have to hypothesise that the relationship
between illness behaviour scores and the onset of IBS
was diﬀerent among those who did and did not partici-
pate. That seems unlikely. However, we may have over-
estimated the prevalence of new IBS. If we assume all
non-participants would have remained symptom freeTable 4
Comparison of baseline measures between non-participantsa and full-partici
Non-participantsa (n = 1976)
n %
Gender
Male 934 47.3
Female 1042 52.7
Total 1976 100
Median 95% CI
Age 44.3 43.6–45.2
n %
Baseline APc status
AP free 1698 85.9
AP 278 14.1
Total 997 100
Median 95% CI
Psychological scales
Sleep Problems 5 4–5
GHQ 0 0–0
Somatic Symptoms 0 0–0
Health Anxiety 9 8–9
Illness Behaviour 4 4–4
HAD Anxiety 5 5–5
HAD Depression 3 2–3
Life Eventsd 1 0–1
a Non-participants include subjects who did not agree to further contact a
follow-up (n = 997).
b All values are by Mann–Whitney U test except gender baseline abdomin
c AP, abdominal pain.
d Life events during the 6 months prior to completion of the baseline quesat follow-up we would have found a minimum preva-
lence of 1.9% (95% CI 1.6–2.3).
Finally, three out of four (Somatic Symptoms Check-
list, Estimated Sleep Problems and HAD Anxiety scales)
of the factors identiﬁed in the multivariate analysis had
conﬁdence intervals that approach signiﬁcance, but that
include unity. However, as reported in this manuscript
the best estimate from the available data indicated that
these factors contributed to the outcome. We therefore
included these factors in our ﬁnal model.
Our results are supported by a previous ﬁnding from
this research group that reported high scores on the ill-
ness behaviour scale and GHQ to be strong risk markers
for the onset of abdominal pain [11]. However, we have
gone further in this study by investigating a more homo-
geneous population, using a clinically meaningful deﬁni-
tion (i.e. strict criteria for IBS rather than more general
abdominal pain), and using a range of markers of dis-
tress. In the current study general psychological distress
(measured by the GHQ) was associated with the out-
come. However this relationship was explained by other
markers of psychological distress in the multivariate
model. Since abdominal pain is also strongly associated
with psychosocial status it may act as a confounder in
the relationship between psychosocial status and thepants at follow-up
Full participants (n = 2456) P-valueb
n %
1092 44.5 0.06
1364 55.5
2456 100
Median 95% CI
47.6 46.9–48.3 <0.01
n %
2129 86.7 0.47
327 13.3
2456 100
Median 95% CI
5 4–5 0.20
0 0–0 0.36
0 0–0 0.14
9 8–9 0.75
4 4–4 0.03
5 5–5 0.12
2 2–3 0.01
1 1–1 0.07
t baseline (n = 979) and those who were non/incomplete responders at
al pain status, which are by v2 test.
tionnaire.
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chosocial factors as risk markers for the onset of IBS
and we therefore adjusted for the potential confounding
eﬀect of abdominal pain. This allowed us to consider the
eﬀect of psychosocial exposures on the onset of IBS,
independent of prior abdominal pain status. Both high
levels of illness behaviour and reporting a greater num-
ber of somatic symptoms are indicative of the process of
somatisation. Research into other chronic unexplained
pain syndromes, in particular chronic widespread pain
(CWP), has reported similar risk markers for symptom
onset [22]. In addition to having similar risk markers,
as might be expected, it has been demonstrated that
these disorders co-occur in the general population.
One recent study reported that in a sample of 587 sub-
jects, 27% were found to have one or more of IBS,
CWP, chronic orofacial pain and chronic fatigue, and
1% was reported to have all four [1]. As this was a
cross-sectional study the authors were unable to con-
sider the aetiology of these syndromes; however they
did examine common factors across the disorders and
reported that high levels of health anxiety, somatic
symptoms and recent adverse life events were common
to all. A second study [8] lends further support to the
existence of overlap of IBS with other functional disor-
ders; in a group of subjects with chronic fatigue syn-
drome a point prevalence of IBS was reported to be
63%. The point prevalence of CWP amongst the group
of subjects with IBS in our study was 33% (n = 28)
and one could hypothesise that the relationships we
have observed are with CWP. Although the numbers
are small we repeated the multivariate analysis stratiﬁed
by the presence of CWP at follow-up. In those who did
not have co-occurring CWP the results were similar to
those reported here for the onset of IBS. However,
depression and threatening life events were additional
markers for predicting those subjects who reported both
IBS and CWP at follow-up.
Why psychosocial risk markers manifest in somatic
symptoms is unclear. It is likely that speciﬁc biological
mechanisms moderate the relationships between these
markers and symptom onset. The hypothalamic-pitui-
tary-adrenal (HPA) axis (the predominant stress–
response axis of the body) has been shown to be
associated with the onset of CWP [23]. The HPA axis
has many functions and is intimately linked with pain.
Clinic studies have suggested that the HPA axis may
also be altered in patients with IBS and other FGIDs
[2]. Whether these alterations are a consequence of hav-
ing IBS or precede the onset of symptoms is unclear and
requires further investigation. Other studies have
demonstrated that psychological factors are important
predictors in the development of IBS following a diag-
nosis of acute gastroenteritis [9,10]. We have added to
these reports by providing evidence for a role of psycho-
social factors in the onset of IBS in the general popula-tion setting, whether diﬀerent mechanisms underlie these
subgroups of IBS remains to be clariﬁed.
In conclusion, the present study has demonstrated
that in a group of subjects free of IBS the reporting of
higher levels of somatic symptoms, illness behaviour,
sleep problems and anxiety are independent predictors
of IBS onset. In order to develop treatment and preven-
tion strategies future work is needed that can explain
how these psychosocial markers result in IBS.Acknowledgements
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